Patent · US Active

TGR5 agonists

US8846739B2 · kind B2 · utility

0Cited by

0References

23Claims

0Family size

Assignee

Exelixis Patent Company LLC · US

Inventors

Venkataiah Bollu · San Diego, US
Brant Clayton Boren · San Diego, US
Jackaline D. Julien · Del Mar, US
Brenton T. Flatt · Poway, US
Nadia Haq · Waltham, US
Sarah Hudson · Limerick, IE
Raju Mohan · Encinitas, US
Michael M. Morrissey · Danville, US
Benjamin Pratt · Encinitas, US

Key dates

Filing date	Aug 11, 2010
Grant date	Sep 30, 2014
Priority date	—
Expiry date	Nov 11, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

TGR5 agonists of structural formula VIII(Q), wherein X, R1, R2, and R5 are defined in the specification, pharmaceutically acceptable salts thereof, compositions thereof, and use of the compounds and compositions for treating diseases. The invention also comprises use of the compounds in and for the manufacture of medicaments, particularly for treating diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.